Predicting response, improving patient outcome
Posted on: Friday, May 29th, 2015
Scott Clark, VP of Global Scientific Operations speaks about Cancer Genetics’ PGx services and how CGI is at the forefront of personalized medicine.
Individuals respond differently to medications based on their genetic profile. For oncology medications, it is extremely important to understand the underlying genetics for safety and efficacy purposes.
Pharmacogenomics can help reduce adverse effects as well as predict efficacy of certain medications. Cancer Genetics offers a comprehensive testing package to help predict patient outcome and aid in drug development. For oncologist, such genomic insight can help in patient management whereas it can help Biopharma companies during drug development.
Helping patient get the right therapy is essential to Cancer Genetics’ work. Cancer Genetics’ pharmacogenomics services puts the company at the forefront of personalized medicine.